MIZUHO MEDY CO.,LTD.

4595 TSE Pharmaceuticals Pharmaceutical
TSE Standard
¥1,690.00
-0.76%
Delayed · cached 15 min
Fair Value Analysis →

Price Chart

Price50-day avg200-day avg

How to read this: the line is the closing price over time. The two dashed lines are moving averages — the average price over the last 50 and 200 trading days — which smooth out daily noise to show the broader trend. Price above its moving averages reflects recent strength; below reflects recent weakness. Use the buttons to change the time range. Prices are end-of-day, not live.

Strengths

  • Low debt: debt-to-equity of 0.2.
  • Return on equity is healthy at 19%.
  • Return on capital employed is healthy at 23.6%.
  • Net profit margin is strong at 30.4%.
  • Current assets comfortably cover current liabilities (current ratio 7.36).
  • Has paid a dividend in each of the last 5 years on record.

!Watch-points

  • Profit growth has been slow over five years (about -8% a year).
  • Sales growth has been slow over five years (about -4% a year).

These points are generated automatically from the company’s reported figures to highlight what stands out. They are descriptive observations for educational purposes only — not advice or a recommendation to buy, sell, or hold.

Forensic Checks

Altman Z-ScoreSafe zone
3.22

In Altman’s original study, companies in this range showed a low incidence of financial distress.

Computed without the market-value term.

Piotroski F-ScoreWeak
1 / 4

The F-Score adds one point for each of several year-on-year signs of improving profitability, lower leverage and better efficiency. Higher is generally stronger.

Based on 4 of the 9 signals — the rest need data not available for this stock.

These are well-known academic screening models, shown for educational context only. They describe historical financial patterns and are not predictions, advice, or a recommendation to buy, sell, or hold.

Key Ratios

Market Cap¥322億
Current Price¥ 1,690.00
High / Low¥ 1,930.00 / 1,582.00
Stock P/E9.979922
Book Value¥ 980.89
Dividend Yield0%
ROCE23.57%
ROE19.00%
Debt to Equity0.20
Current Ratio7.36
P/B Ratio1.7350559
EPS¥ 179.84
PAT Margin30.42%
Compounded Sales Growth
10 Years
5 Years -3.78%
3 Years
TTM
Compounded Profit Growth
10 Years
5 Years -8.17%
3 Years
TTM
Stock Price CAGR
10 Years
5 Years
3 Years
1 Year
Return on Equity
10 Years
5 Years
3 Years
Last Year 19.00%
Educational data only. Not a recommendation to buy, sell or hold any security.